Repligen Corporation

NasdaqGS:RGEN Stock Report

Market Cap: US$7.2b

Repligen Corporation Company Information

Repligen Corporation's employee growth, exchange listings and data sources

Key Information

  • Name: Repligen Corporation
  • Ticker: RGEN
  • Exchange: NasdaqGS
  • Founded: 1981
  • Industry: Life Sciences Tools and Services
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$7.199b
  • Shares Outstanding: 56.03m
  • Website: https://www.repligen.com

Number of Employees

Location

  • Repligen Corporation
  • Building 1
  • Suite 100
  • Waltham
  • Massachusetts
  • 02453
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
RGENNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDApr 1986
RGNDB (Deutsche Boerse AG)YesCommon StockDEEURApr 1986
R2GE34BOVESPA (Bolsa de Valores de Sao Paulo)BDR EACH 30 REPR 1 COMBRBRLJan 2022

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/20 17:39
End of Day Share Price 2024/11/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.